John Lilja

A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden.

Part of Eurofins Scientific SE, Eurofins Genomics Europe Genotyping A/S is a Danish company that provides genomic solutions for the development of new drugs. The company is based in Aarhus, Denmark. Eurofins Genomics Europe Genotyping was acquired by Eurofins Scientific SE on February 21, 2013.

Brixton Medical AB breeds horses and other equine animals. The private company is based in Stockholm, Sweden. The CEO of the Swedish company is Daniel Redén.

Vivolux AB develops biotechnology for anticancer drugs. The private company is based in Gothenburg, Sweden.

Sweden Carnica Group AB develops and offers consultancy and research services within the information technology sector. It also provides assistance in broadband, applications, and Video on Demand. The company is headquartered in Gavle, Sweden.

BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden.

Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden.

Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden.

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden.

Navinci Diagnostics AB is a Swedish biotech company that specializes in innovative proximity ligation assay-based solutions for spatial proteomics. Navinci Diagnostics is based in Uppsala County, SE. The company's resources section offers a variety of instructions, protocols, informative whitepapers, and scientific posters. The CEO of the company is Carl Robert Gunnarsson.